CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
68.92
-0.28 (-0.40%)
At close: Apr 15, 2025, 4:00 PM
68.97
+0.05 (0.07%)
After-hours: Apr 15, 2025, 7:04 PM EDT
CVS Health Market Cap
CVS Health has a market cap or net worth of $87.00 billion as of April 15, 2025. Its market cap has decreased by -13.32% in one year.
Market Cap
87.00B
Enterprise Value
158.93B
1-Year Change
-13.32%
Ranking
Category
Stock Price
$68.92
Market Cap Chart
Since December 1, 1998, CVS Health's market cap has increased from $19.55B to $87.00B, an increase of 345.07%. That is a compound annual growth rate of 5.82%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 14, 2025 | 87.25B | 54.45% |
Dec 31, 2024 | 56.49B | -44.41% |
Dec 29, 2023 | 101.61B | -17.02% |
Dec 30, 2022 | 122.45B | -10.08% |
Dec 31, 2021 | 136.18B | 52.33% |
Dec 31, 2020 | 89.40B | -7.50% |
Dec 31, 2019 | 96.65B | 44.79% |
Dec 31, 2018 | 66.75B | -9.11% |
Dec 29, 2017 | 73.44B | -12.73% |
Dec 30, 2016 | 84.15B | -22.27% |
Dec 31, 2015 | 108.26B | -1.94% |
Dec 31, 2014 | 110.41B | 29.61% |
Dec 31, 2013 | 85.19B | 41.32% |
Dec 31, 2012 | 60.28B | 13.56% |
Dec 30, 2011 | 53.08B | 12.35% |
Dec 31, 2010 | 47.25B | 3.99% |
Dec 31, 2009 | 45.43B | 10.07% |
Dec 31, 2008 | 41.28B | -29.69% |
Dec 31, 2007 | 58.71B | 130.61% |
Dec 29, 2006 | 25.46B | 18.34% |
Dec 30, 2005 | 21.51B | 19.30% |
Dec 31, 2004 | 18.03B | 26.40% |
Dec 31, 2003 | 14.27B | 45.39% |
Dec 31, 2002 | 9.81B | -15.18% |
Dec 31, 2001 | 11.57B | -50.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.40B |
UnitedHealth Group | 536.99B |
Johnson & Johnson | 371.98B |
AbbVie | 316.82B |
Novo Nordisk | 294.67B |
Abbott Laboratories | 221.92B |
AstraZeneca | 210.97B |
Novartis AG | 206.74B |